Gideon Rechavi

Medicine & Life Sciences

1. Genes 100%
2. RNA Editing 73%
3. Mutation 63%
4. Neoplasms 55%
5. Transcriptome 45%
6. Gene Expression 42%
7. Precursor Cell Lymphoblastic Leukemia-Lymphoma 38%
8. Inosine 36%
9. RNA 35%
10. Messenger RNA 35%
11. T-Lymphocytes 33%
12. Severe Combined Immunodeficiency 32%
13. Proteins 31%
14. Leukemia 30%
15. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 29%
16. DNA 28%
17. Fluorescence In Situ Hybridization 27%
18. Pediatrics 27%
19. Adenosine 26%
20. Child 25%
21. Neuroblastoma 25%
22. Genome 23%
23. Immunoglobulin Genes 23%
24. immune RNA 22%
25. Phenotype 22%
26. Stem Cells 22%
27. Glioblastoma 22%
28. Spectral Karyotyping 22%
29. Chromosome Aberrations 21%
30. N(6)-methyladenosine 21%
31. B-Lymphocytes 21%
32. Gene Expression Profiling 20%
33. Down-Regulation 20%
34. farnesylthiosalicylic acid 19%
35. Chromosomes 19%
36. Apoptosis 18%
37. Cell Line 18%
38. mos Genes 18%
39. Burkitt Lymphoma 17%
40. Clone Cells 17%
41. Hepcidins 17%
42. Oligonucleotide Array Sequence Analysis 17%
43. T-Cell Antigen Receptor 16%
44. Iron 16%
45. Immunoglobulin Heavy Chains 15%
46. Brain Neoplasms 15%
47. p53 Genes 15%
48. Growth 15%
49. Spalax 15%
50. Therapeutics 15%